Provider 1790739282
NPI: 1790739282Share
Active Billing Period:2018-01→2020-12(36 months)
Billing appears to have stoppedLast active: 2020-12
Extreme procedure concentration — 100% of $9.4M billed through a single code
Total Paid
$9.4M
$9,430,257
Total Claims
30K
Beneficiaries
1,748
17.0 claims/patient
Avg Cost/Claim
$317
Monthly Spending Trend
Yearly Spending
2018
$3.4M
+10%
2019
$3.8M
-41%
2020
$2.2M
Procedure Breakdown
Cost per claim compared to national benchmarks
This provider bills for 1 distinct procedure code. The top code (Q5003 (Injection, infliximab-dyyb, biosimilar, 10 mg)) accounts for 100% of total spending.
ProcedureTotalYour Cost/ClaimNational Medianvs MedianPercentile
$9.4M
30K claims
$316.97
$177.99
1.8×
Normal range
Q5003Normal range
Injection, infliximab-dyyb, biosimilar, 10 mg
$9.4M
30K claims · 100.0%
Your Cost: $316.97/claim|Median: $177.99
1.8× median